long term tirzepatide Results Timeline: What to Expect Tirzepatide Reduces Risk of Type
Description
Tirzepatide is an injectable medication that mimics two key hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), to regulate blood sugar and appetite
En todos los casos, el uso debe evaluarse individualmente y bajo criterio mdico
This was in people with obesity, particularly at high doses
Switching from Mounjaro (tirzepatide) to Wegovy (semaglutide) should only be done under medical supervision
Examples include liraglutide (Victoza) and semaglutide (Ozempic)
